Event Calendar - 2023 Events

Event Calendar - 2023 Events

November 28, 2023
London, UK

Read the media release

Download the podcast (MP3 102 MB)

Access our interactive presentation (PDF 17 MB)

November 15, 2023
London, UK

November 13, 2023

Novartis 10th annual ESG investor event

Download the presentation (PDF 9.9 MB)
 

November 08, 2023
Miami, USA

October 24, 2023
Basel, Switzerland

Media release:
English (PDF 0.4 MB) | Deutsch (PDF 0.4 MB) | Français (PDF 0.5 MB)

Interim financial report (PDF 0.6 MB)

Download the podcast (MP3 33 MB)

Download the interactive presentation (PDF 3.5 MB)

Novartis Q3 2023 Impact and Sustainability Update (PDF 1.0 MB)

October 24, 2023
Basel, Switzerland

Download the podcast (MP3 24 MB)

Download the presentation (PDF 1.0 MB)

October 10, 2023

Download the presentation (PDF 0.4 MB)

September 15, 2023 
Basel, Switzerland

Visit the General Meetings section

Sep 13, 2023
London, UK

Sep 12, 2023
New York, USA

September 06, 2023
Boston, USA

July 18, 2023
Basel, Switzerland

Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)

Condensed financial report (PDF 0.5 MB)

Download the interactive presentation (PDF 3.4 MB)

Download the podcast (MP3 34 MB)

Read the presentation transcript

Novartis Q2 2023 Impact and Sustainability Update (PDF 0.3 MB)

June 29, 2023
Bordeaux, France

June 22, 2023
London, UK

June 21, 2023
London, UK

June 12, 2023
Dana Point, USA

June 08, 2023
New York, USA

Download the podcast (MP3 160 MB)

June 12, 2023
London, UK

Download the podcast (MP3 111 MB)

Read the media release

Download the presentation (PDF 11 MB)

June 04, 2023
Chicago, USA

Read the media release

Download the presentation (PDF 1.2 MB)

May 09, 2023
Las Vegas, USA

April 26, 2023

Today Novartis has published updated 2022 quarterly and full year segment financials reflecting transfers of Sandoz biotechnology manufacturing services to other companies’ activities and the Coartem® brand from Sandoz to the Innovative Medicines Division, which were effective as of January 1, 2023. The 2022 updated segment financial reporting is provided in accordance with requirements of IFRS, and to aid comparability of 2023 quarterly and full year results for the segments and Corporate.

Download the presentation (PDF 0.4 MB)

April 25, 2023
Basel, Switzerland

Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)

Condensed financial report (PDF 0.3 MB)

Download the interactive presentation (PDF 3.4 MB)

Download the podcast (MP3 34 MB)

Read the presentation transcript

Novartis Q1 2023 Impact and Sustainability Update (PDF 1.9 MB)

March 14, 2023
Miami, USA

March 07, 2023
Basel, Switzerland

Visit the General Meetings section

March 07, 2023
Boston, USA

March 01, 2023
London, UK

February 21, 2023
Virtual

February 14, 2023
Virtual

February 08, 2023
Virtual

February 01, 2023
Basel, Switzerland

Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)

Condensed financial report (PDF 0.5 MB)

Download the presentation (PDF 5.1 MB)

Download the podcast (MP3 45 MB)

Read the presentation transcript

Novartis ESG Update Q4 2022 (PDF 0.9 MB)

January 09, 2023
San Francisco, USA

Download the presentation (PDF 2.7 MB)

Download the podcast (MP3 18 MB)
 

 

Source URL: https://prod1.novartis.com/node/546201

List of links present in page
  1. https://prod1.novartis.com/node/546201
  2. https://prod1.novartis.com/news/media-releases/novartis-upgrades-mid-term-sales-growth-guidance-showcases-its-differentiated-innovative-medicines-strategy-and-robust-pipeline-rd-day
  3. https://prod1.novartis.com/sites/novartis_com/files/2023-12/novartis-investors-r-d-day-2023.mp3
  4. https://prod1.novartis.com/sites/novartiscom/files/novartis-investors-r-d-day-2023.pdf
  5. https://prod1.novartis.com/sites/novartiscom/files/2023-11-novartis-investor-impact-health-equity.pdf
  6. https://prod1.novartis.com/sites/novartis_com/files/q3-2023-media-release-en.pdf
  7. https://prod1.novartis.com/sites/novartis_com/files/q3-2023-media-release-de.pdf
  8. https://prod1.novartis.com/sites/novartis_com/files/q3-2023-media-release-fr.pdf
  9. https://prod1.novartis.com/sites/novartis_com/files/2023-10-interim-financial-report-en.pdf
  10. https://prod1.novartis.com/sites/novartis_com/files/2023-10/q3-2023-investor-presentation.mp3
  11. https://prod1.novartis.com/sites/novartis_com/files/q3-2023-investor-presentation.pdf
  12. https://prod1.novartis.com/sites/novartis_com/files/novartis-q3-2023-impact-and-sustainability-update.pdf
  13. https://prod1.novartis.com/sites/novartis_com/files/2023-10/2023-novartis-esmo-call-presentation.mp3
  14. https://prod1.novartis.com/sites/novartis_com/files/2023-novartis-esmo-call-presentation.pdf
  15. https://prod1.novartis.com/sites/novartis_com/files/novartis-results-continuing-operations-october-2023.pdf
  16. https://prod1.novartis.com/investors/shareholder-information/general-meetings
  17. https://prod1.novartis.com/sites/novartis_com/files/q2-2023-media-release-en.pdf
  18. https://prod1.novartis.com/sites/novartis_com/files/q2-2023-media-release-de.pdf
  19. https://prod1.novartis.com/sites/novartis_com/files/q2-2023-media-release-fr.pdf
  20. https://prod1.novartis.com/sites/novartis_com/files/2023-07-interim-financial-report-en.pdf
  21. https://prod1.novartis.com/sites/novartis_com/files/q2-2023-investor-presentation.pdf
  22. https://prod1.novartis.com/sites/novartis_com/files/2023-07/q2-2023-investor-presentation.mp3
  23. https://prod1.novartis.com/investors/financial-data/quarterly-results/2023-q2-transcript
  24. https://prod1.novartis.com/sites/novartis_com/files/novartis-q2-2023-impact-and-sustainability-update.pdf
  25. https://prod1.novartis.com/sites/novartis_com/files/2023-06/sandoz-capital-markets-day-new-york.mp3
  26. https://prod1.novartis.com/sites/novartis_com/files/2023-06/sandoz-capital-markets-day-london.mp3
  27. https://prod1.novartis.com/news/media-releases/sandoz-presents-compelling-investment-proposition-standalone-company-capital-markets-day
  28. https://prod1.novartis.com/sites/novartis_com/files/2023-sandoz-capital-markets-day-presentation.pdf
  29. https://prod1.novartis.com/news/media-releases/novartis-kisqali-significantly-reduced-risk-recurrence-25-across-broad-population-patients-early-breast-cancer-clinically-meaningful-benefit-was-consistent-across-subgroups
  30. https://prod1.novartis.com/sites/novartis_com/files/2023-06-novartis-asco-presentation.pdf
  31. https://prod1.novartis.com/sites/novartis_com/files/novartis-2022-financials-updated-segment-reporting-april-2023.pdf
  32. https://prod1.novartis.com/sites/novartis_com/files/q1-2023-media-release-en.pdf
  33. https://prod1.novartis.com/sites/novartis_com/files/q1-2023-media-release-de.pdf
  34. https://prod1.novartis.com/sites/novartis_com/files/q1-2023-media-release-fr.pdf
  35. https://prod1.novartis.com/sites/novartis_com/files/2023-04-interim-financial-report-en.pdf
  36. https://prod1.novartis.com/sites/novartis_com/files/q1-2023-investor-presentation.pdf
  37. https://prod1.novartis.com/sites/novartis_com/files/2023-04/q1-2023-investor-presentation.mp3
  38. https://prod1.novartis.com/investors/financial-data/quarterly-results/2023-q1-transcript
  39. https://prod1.novartis.com/sites/novartis_com/files/novartis-q1-2023-impact-and-sustainability-update.pdf
  40. https://prod1.novartis.com/investors/shareholder-information/general-meetings
  41. https://prod1.novartis.com/sites/novartis_com/files/q4-2022-media-release-en.pdf
  42. https://prod1.novartis.com/sites/novartis_com/files/q4-2022-media-release-de.pdf
  43. https://prod1.novartis.com/sites/novartis_com/files/q4-2022-media-release-fr.pdf
  44. https://prod1.novartis.com/sites/novartis_com/files/2023-02-interim-financial-report-en.pdf
  45. https://prod1.novartis.com/sites/novartis_com/files/q4-2022-investor-presentation.pdf
  46. https://prod1.novartis.com/sites/novartis_com/files/2023-02/q4-2022-investor-presentation.mp3
  47. https://prod1.novartis.com/investors/financial-data/quarterly-results/2022-q4-and-full-year-results-transcript
  48. https://prod1.novartis.com/sites/novartis_com/files/environmental-social-and-governance-february-2023-update.pdf
  49. https://prod1.novartis.com/sites/novartis_com/files/2023-new-novartis-pure-play-innovative-medicines-company.pdf
  50. https://prod1.novartis.com/sites/novartis_com/files/2023-01/2023-new-novartis-pure-play-innovative-medicines-company.mp3
  51. https://prod1.novartis.com/node/546201/printable/print
  52. https://prod1.novartis.com/node/546201/printable/pdf